Greg Share – Chairman.
Greg Share is President of Ambina Partners, a private investment firm focused on investing in financial services and software companies. Mr. Share has over twenty years of private equity experience and previously led software and financial services investing at Moelis Capital Partners, a mid-market private equity fund where he was a Partner and Investment Committee Member from 2008 until 2015. Prior to joining Moelis, Mr. Share served as a Managing Director of Fortress Investment Group from 2003 to 2008. Before joining Fortress, Mr. Share was a Vice President at Madison Dearborn Partners and started his investment career at Lazard Freres.
Mr. Share currently holds Board Member roles with several privately-held companies in addition to PeriGen, Inc. They include Princeton Hosted Solutions (Telecom), Veritas Financial Partners (Specialty Finance), and Washify (Retail SAAS Software).
Previously, Mr. Share served as Chairman of Kinsale Capital Group (NASDAQ: KNSL), a specialty insurer, and as a board member with EPIQ Systems (NASDAQ: EPIQ), a leading provider of e-discovery solutions, as well as several privately-held businesses including Insurance Technologies (Insurance Software), Mxi Technologies (ERP Software), OneTitle National Guaranty Company (Title Insurer), and SwipeClock (HR Software).
John Gomez – Director.
John Gomez is the Chief Executive Officer of Sensato, a company providing cyber-security, privacy and compliance assessments to healthcare information technology organizations and vendors. During is career he has run both small and large organization in roles involving R&D, product strategy, planning, consulting, product support, sales and marketing. His industry experience includes healthcare, telecom, media, federal, security, energy, and consumer markets.
Mr. Gomez has been described as a very hands-leader who focuses on achieving long-term, sustainable growth driven by short-term achievements. He believes clear goals, vision, and objectives are essential for success.
His key achievements included being called “the Steve Jobs of Healthcare” by HISTALK, the leading HIT blog in North America, being selected as one of the top-100 Hispanic IT leaders, and developing a profitable international business unit from $0 to more than $100 million in 36 months that was breakeven from year one.
Mr. Gomez has held leadership positions at JGo Labs, Group Espada, Allscripts, WebMD, Brill Media, and Contentville.
Cathy Wong – Director.
Cathy Wong is a Director at Trident Capital, a multistage venture capital firm that has invested in over 180 companies since inception in 1983. Cathy also serves on the Board of Directors of Extole.
Prior to joining Trident Capital in 2016, Cathy spent over 10 years at L-3 Communications’ Electron Devices Division, a manufacturer of microwave vacuum electron devices for the industrial, medical and defense markets. At L-3, Cathy held a number of Operations and Finance roles, including Bids & Proposals.
Before L-3, Cathy spent time in the FP&A group at Support.com (SPRT), the venture investment team at Ridgewood Capital and the investment banking organization at Merrill Lynch. Ridgewood Capital, part of the Ridgewood Energy private equity firm with over $3b under management, invested in early and late stage technology companies.
A Bay Area native, Cathy earned her B.S. degree in Business Administration from the University of California at Berkeley, Walter A. Haas School of Business.
David. W. Jahns – Director.
Mr. Jahns is a Managing Director of Galen Partners, a leading healthcare growth equity investment firm founded in 1990. With experience in over 70 growth equity investments, Mr. Jahns has developed substantial expertise and leadership in working with entrepreneurs to build market-leading healthcare companies in the areas of medical devices and technology-enabled services. Prior to joining Galen in 1993, Mr. Jahns was an investment banker and financial advisor to healthcare companies. He worked in the Corporate Finance Department at Smith Barney, Inc. in New York, specializing in public offerings and mergers and acquisitions, as well as public debt financings. As an investment banker and venture capitalist, Mr. Jahns has worked on more than 20 initial public offerings, including 11 Galen portfolio companies’ IPOs. Additionally, he has extensive M&A experience including 19 portfolio companies’ sales to financial and strategic buyers.
Mr. Jahns has served on numerous public company Boards of Directors and currently serves several Galen portfolio companies including: CBL Pathology, Dakim Brain Fitness, Unisyn Medical Technologies, PeriGen, InTouch Health, and USHIFU.
Mr. Jahns earned an MBA from the Northwestern University, Kellogg School of Management, where he specialized in Health Services Management and is currently a guest lecturer on private equity and venture capital case studies. He earned his BA in political science and economics from Colgate University, where he graduated Phi Beta Kappa.